{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:07:00Z","timestamp":1789913220614,"version":"4.0.1"},"reference-count":42,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["CYTOVAC project"],"award-info":[{"award-number":["CYTOVAC project"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["ProA"],"award-info":[{"award-number":["ProA"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006021","name":"Direction G\u00e9n\u00e9rale de l\u2019Armement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["Passerelle Grant"],"award-info":[{"award-number":["Passerelle Grant"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01533","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T04:13:25Z","timestamp":1510632805000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection"],"prefix":"10.3389","volume":"8","author":[{"given":"Nadia","family":"Belmellat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Semerano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noria","family":"Segueni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Damotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Ryffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Quesniaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christophe","family":"Boissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Assier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cytogfr.2013.12.005","article-title":"Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice","volume":"25","author":"Winsauer","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jbspin.2016.07.007","article-title":"Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review","volume":"83","author":"Minichiello","year":"2016","journal-title":"Joint Bone Spine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1503\/cmaj.091391","article-title":"A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview","volume":"181","author":"Singh","year":"2009","journal-title":"CMAJ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/QCO.0b013e32832dda55","article-title":"Infectious complications of tumor necrosis factor blockade","volume":"22","author":"Wallis","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor-\u03b1-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19442","DOI":"10.1073\/pnas.0604827103","article-title":"TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation","volume":"103","author":"Le Buanec","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1136\/ard.2007.079137","article-title":"Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalpha","volume":"67","author":"Delavall\u00e9e","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1128\/CVI.05649-11","article-title":"Modulation of anti-tumor necrosis factor alpha (TNF-\u03b1) antibody secretion in mice immunized with TNF-\u03b1 kinoid","volume":"19","author":"Assier","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/cei.12040","article-title":"Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-\u03b1 immunotherapy in human TNF-\u03b1 transgenic mice depends on anti-TNF-\u03b1 antibody levels","volume":"172","author":"Semerano","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1186\/ar2897","article-title":"Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis","volume":"11","author":"Delavall\u00e9e","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e113465","DOI":"10.1371\/journal.pone.0113465","article-title":"Therapeutic vaccination with TNF-kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial","volume":"9","author":"Durez","year":"2014","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1086\/429996","article-title":"Reactivation of latent granulomatous infections by infliximab","volume":"41","author":"Wallis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/1756-185X.12970","article-title":"Comparison of the risk of infections in different anti-TNF agents: a meta-analysis","volume":"20","author":"Liao","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.1073\/pnas.94.15.8093","article-title":"Characterization of tumor necrosis factor-deficient mice","volume":"94","author":"Marino","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"9329","DOI":"10.1016\/j.vaccine.2011.09.134","article-title":"Active immunization against IL-23p19 improves experimental arthritis","volume":"29","author":"Ratsimandresy","year":"2011","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jim.2009","article-title":"Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies","volume":"343","author":"Hutamekalin","year":"2009","journal-title":"J Immunol Methods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10456-015-9487-0","article-title":"Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis","volume":"19","author":"Semerano","year":"2016","journal-title":"Angiogenesis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jbspin.2017.04.005","article-title":"Do we need animal models to advance research on inflammatory joint disease?","volume":"84","author":"Boissier","year":"2017","journal-title":"Joint Bone Spine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1086\/648724","article-title":"Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy","volume":"50","author":"Hage","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B20","first-page":"854","article-title":"Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience","volume":"26","author":"Pe\u00f1a-Sagredo","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jbspin.2013.07.009","article-title":"Risk of herpes\/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis","volume":"81","author":"Che","year":"2014","journal-title":"Joint Bone Spine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.4049\/jimmunol.178.11.7450","article-title":"A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis","volume":"178","author":"Spohn","year":"2007","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cellimm.2009.03.014","article-title":"The preventive effect of adjuvant-free administration of TNF-PADRE autovaccine on collagen-II-induced rheumatoid arthritis in mice","volume":"258","author":"Wan","year":"2009","journal-title":"Cell Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0163080","DOI":"10.1371\/journal.pone.0163080","article-title":"A rationally designed TNF-\u03b1 epitope-scaffold immunogen induces sustained antibody response and alleviates collagen-induced arthritis in mice","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semarthrit.2005.01.009","article-title":"Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab","volume":"34","author":"Wallis","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1086\/517519","article-title":"Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis","volume":"195","author":"Plessner","year":"2007","journal-title":"J Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/iid3.9","article-title":"Relative contribution of IL-1\u03b1, IL-1\u03b2 and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG","volume":"1","author":"Bourigault","year":"2013","journal-title":"Immun Inflamm Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1073\/pnas.94.10.5243","article-title":"Identification of nitric oxide synthase as a protective locus against tuberculosis","volume":"94","author":"MacMicking","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.160.4.1796","article-title":"Effects of aminoguanidine on latent murine tuberculosis","volume":"160","author":"Flynn","year":"1998","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0153217","DOI":"10.1371\/journal.pone.0153217","article-title":"Different risk of tuberculosis and efficacy of isoniazid prophylaxis in rheumatoid arthritis patients with biologic therapy: a nationwide retrospective cohort study in Taiwan","volume":"11","author":"Liao","year":"2016","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1128\/IAI.00083-16","article-title":"Effects of B cell depletion on early Mycobacterium tuberculosis infection in cynomolgus macaques","volume":"84","author":"Phuah","year":"2016","journal-title":"Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1134\/S0006297914120098","article-title":"Formation of compact aggregates of B-lymphocytes in lung tissue during mycobacterial infection in mice depends on TNF production by these cells and is not an element of the host\u2019s immunological protection","volume":"79","author":"Kondratieva","year":"2014","journal-title":"Biochemistry (Mosc)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","article-title":"Tumour necrosis factor antagonists: structure, function, and tuberculosis risks","volume":"8","author":"Wallis","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04146.x","article-title":"How tumour necrosis factor blockers interfere with tuberculosis immunity","volume":"161","author":"Harris","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.4049\/jimmunol.168.7.3394","article-title":"Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Gu\u00e9rin infection in the absence of secreted TNF and lymphotoxin-alpha","volume":"168","author":"Olleros","year":"2002","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1465-9921-6-136","article-title":"Membrane TNF confers protection to acute mycobacterial infection","volume":"6","author":"Fremond","year":"2005","journal-title":"Respir Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.tube.2007.08.011","article-title":"Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence","volume":"88","author":"Dambuza","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0002-9440(10)61250-3","article-title":"Membrane tumor necrosis factor confers partial protection to Listeria infection","volume":"167","author":"Torres","year":"2005","journal-title":"Am J Pathol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1128\/IAI.02004-05","article-title":"Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection","volume":"74","author":"Musicki","year":"2006","journal-title":"Infect Immun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/364798a0","article-title":"Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes","volume":"364","author":"Rothe","year":"1993","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"6954","DOI":"10.1128\/IAI.68.12.6954-6961.2000","article-title":"Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent","volume":"68","author":"Bekker","year":"2000","journal-title":"Infect Immun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01533\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:53:10Z","timestamp":1693227190000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01533\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2017.01533"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01533","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"article-number":"1533"}}